Literature DB >> 18252885

Atherosclerotic plaque composition and occurrence of restenosis after carotid endarterectomy.

Willem E Hellings1, Frans L Moll, Jean-Paul P M De Vries, Rob G A Ackerstaff, Kees A Seldenrijk, Rosemarie Met, Evelyn Velema, Wouter J M Derksen, Dominique P V De Kleijn, Gerard Pasterkamp.   

Abstract

CONTEXT: Previous studies have assessed the predictive value of clinical and angiographic parameters for development of restenosis after vascular interventions. The composition of the atherosclerotic plaque at the intervention site has had limited evaluated as a marker for restenosis [corrected].
OBJECTIVE: To investigate the relationship between atherosclerotic plaque histology and the occurrence of restenosis after carotid endarterectomy. DESIGN, SETTING, AND PATIENTS: The Athero-Express study is a longitudinal vascular biobank study that includes the collection of atherosclerotic plaques of patients undergoing primary carotid endarterectomy. Five hundred patients were prospectively followed up between April 1, 2002, and March 14, 2006, to assess carotid artery restenosis measured by duplex ultrasound 1 year after the intervention. MAIN OUTCOME MEASURES: Risk of carotid restenosis in relation to predefined histological characteristics (macrophage and smooth muscle cell infiltration, collagen, calcifications, intraplaque bleeding, luminal thrombus, and lipid core size), adjusted for clinical characteristics (multivariate logistic regression analysis).
RESULTS: At 1 year, 85 patients (17%) developed 50% or greater restenosis, including 40 patients (8%) who developed 70% or greater restenosis of the target vessel. Patients whose histological examination of the plaque revealed marked macrophage infiltration (n = 286) had a lower risk than those with none or minor macrophage infiltration (n = 214) of developing 50% or greater restenosis (risk difference, 11.5% vs 24.3%; adjusted odds ratio [OR], 0.43; 95% confidence interval [CI], 0.26-0.72) and a lower risk of developing 70% or greater restenosis (risk difference, 4.5% vs 12.6%; adjusted OR, 0.36; 95% CI, 0.17-0.74). Patients (n = 177) with a plaque having a large lipid core size (>40%) had a lower risk than those (n = 94) with a plaque having a lipid core size of less than 10% of developing 50% or greater restenosis (risk difference, 11.3% vs 25.5%; adjusted OR, 0.40; 95% CI, 0.19-0.81) and a lower risk of developing 70% or greater restenosis (risk difference, 5.6% vs 14.9%; adjusted OR, 0.42; 95% CI, 0.17-1.04), independent of clinical characteristics.
CONCLUSIONS: Plaque composition is an independent predictor of restenosis after carotid endarterectomy. The dissection of a lipid-rich, inflammatory plaque is associated with reduced risk of restenosis.

Entities:  

Mesh:

Year:  2008        PMID: 18252885     DOI: 10.1001/jama.299.5.547

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

1.  Long-term Comparative Outcomes of Carotid Artery Stenting Following Previous Carotid Endarterectomy vs De Novo Lesions.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Maher Kali; Michael Yacoub; Patrick Stone; Mark C Bates
Journal:  J Endovasc Ther       Date:  2015-04-15       Impact factor: 3.487

2.  Combining Subharmonic and Ultraharmonic Modes for Intravascular Ultrasound Imaging: A Preliminary Evaluation.

Authors:  Himanshu Shekhar; Jeffrey S Rowan; Marvin M Doyley
Journal:  Ultrasound Med Biol       Date:  2017-08-26       Impact factor: 2.998

Review 3.  Imaging Approaches to the Diagnosis of Vascular Diseases.

Authors:  Olga A Gimnich; Ahsan Zil-E-Ali; Gerd Brunner
Journal:  Curr Atheroscler Rep       Date:  2022-01-26       Impact factor: 5.113

4.  10-years experience with the Athero-Express study.

Authors:  Willem E Hellings; Frans L Moll; Dominique P V de Kleijn; Gerard Pasterkamp
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

5.  The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT).

Authors:  Gerd Brunner; Eric Y Yang; Anirudh Kumar; Wensheng Sun; Salim S Virani; Smita I Negi; Tyler Murray; Peter H Lin; Ron C Hoogeveen; Changyi Chen; Jing-Fei Dong; Panagiotis Kougias; Addison Taylor; Alan B Lumsden; Vijay Nambi; Christie M Ballantyne; Joel D Morrisett
Journal:  Atherosclerosis       Date:  2013-10-16       Impact factor: 5.162

6.  Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study.

Authors:  Imo E Hoefer; Jan-Willem Sels; J Wouter Jukema; Sandrin Bergheanu; Erik Biessen; Elizabeth McClellan; Mat Daemen; Pieter Doevendans; Philip de Groot; Marieke Hillaert; Sebastiaan Horsman; Mustafa Ilhan; Johan Kuiper; Nico Pijls; Ken Redekop; Peter van der Spek; Andrew Stubbs; Eric van de Veer; Johannes Waltenberger; Anton-Jan van Zonneveld; Gerard Pasterkamp
Journal:  Clin Res Cardiol       Date:  2013-08-23       Impact factor: 5.460

7.  Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque.

Authors:  Guus W van Lammeren; Frans L Moll; Gert Jan De Borst; Dominique P V de Kleijn; Jean-Paul P M de Vries; Gerard Pasterkamp
Journal:  Curr Cardiol Rev       Date:  2011-02

8.  Biobanking in atherosclerotic disease, opportunities and pitfalls.

Authors:  V P W Scholtes; J P P M de Vries; L M Catanzariti; D P V de Kleijn; F L Moll; G J de Borst; G Pasterkamp
Journal:  Curr Cardiol Rev       Date:  2011-02

Review 9.  Vascular Macrophages in Atherosclerosis.

Authors:  Hailin Xu; Jingxin Jiang; Wuzhen Chen; Wenlu Li; Zhigang Chen
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

Review 10.  The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the Suppression of Intimal Hyperplasia: An Evidence-Based Review.

Authors:  Rohaina Che Man; Nadiah Sulaiman; Mohamad Fikeri Ishak; Ruszymah Bt Hj Idrus; Mohd Ramzisham Abdul Rahman; Muhammad Dain Yazid
Journal:  Int J Environ Res Public Health       Date:  2020-10-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.